The combination regimen of paclitaxel (Taxol) and cisplatin (Platinol) for non–small-cell lung cancer has shown improved response rates in some phase II trials, and because of its safety profile, it could offer patients with this
L Crinó, MD
Advertisement
Articles by L Crinó, MD
Advertisement
Latest Updated Articles
- Quality-of-Life Improvement in Patients Receiving Paclitaxel/Platinum Regimens
Published: September 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
2
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
3
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
4
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
5
